Zobrazeno 1 - 10
of 49
pro vyhledávání: '"E, Daziano"'
Publikováno v:
The Italian journal of gastroenterology. 24(3)
Seven carriers of the Hepatitis B surface antigen who had acquired a form of chronic hepatitis D in the recent past were treated with lymphoblastoid alpha interferon (IFN) (10 MU three times weekly for 4 months, 6 MU three times weekly for other 8 mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58e832ab8604e635b9a5f79155956515
https://pubmed.ncbi.nlm.nih.gov/1562748
https://pubmed.ncbi.nlm.nih.gov/1562748
Publikováno v:
Minerva medica. 81(11)
In order to evaluate the usefulness of Tag 72--tumor associated antigen assay--in gastroenterology, we have studied with Ca 72-4 radioimmunoassay (Centocor) 551 patients suffering benign (233) and neoplastic (318) gastrointestinal diseases and 205 no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2312bc67c1163d720c8b794f9d7f5bcf
https://pubmed.ncbi.nlm.nih.gov/2255410
https://pubmed.ncbi.nlm.nih.gov/2255410
Publikováno v:
The Journal of nuclear medicine and allied sciences. 34
The purpose of the present study was to examine the relationship between the "tumor markers" Ca 19-9, Ca 50 and Ca 195 and benign pancreatic and biliary tract diseases. We measured serum Ca 19-9, Ca 50 and Ca 195 values in 144 subjects with biliary t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0a34d924662c5c6e54726f6a8e1cdbf
https://pubmed.ncbi.nlm.nih.gov/2092159
https://pubmed.ncbi.nlm.nih.gov/2092159
Publikováno v:
The International journal of biological markers. 5(2)
In order to evaluate the usefulness of Ca 72.4 tumor associated antigen assay in gastrointestinal diseases, we have studied 751 patients suffering from benign (376) and neoplastic (375) digestive diseases and 305 normal controls. The cut-off point wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad759f1acb1396ddff1a37fffa5433da
https://pubmed.ncbi.nlm.nih.gov/2283481
https://pubmed.ncbi.nlm.nih.gov/2283481
Autor:
Carlos Solano-Gaviño, Juan1 jsolano@unitru.edu.pe, Siche, Raúl1 rsiche@unitru.edu.pe
Publikováno v:
International Journal on Food System Dynamics. 2024, Vol. 15 Issue 1, p29-43. 15p.
Publikováno v:
Sustainability (2071-1050); Nov2024, Vol. 16 Issue 21, p9146, 23p
Autor:
Ottesen, Andri1 (AUTHOR) a.ottesen@au.edu.kw, Banna, Sumayya2 (AUTHOR), Alzougool, Basil2 (AUTHOR)
Publikováno v:
Energies (19961073). May2023, Vol. 16 Issue 9, p3756. 24p.
Publikováno v:
Sustainability (2071-1050); Sep2024, Vol. 16 Issue 17, p7454, 32p
Publikováno v:
The Journal of nuclear medicine and allied sciences. 33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4bfdcce17fb14b072c55546b2721836d
https://pubmed.ncbi.nlm.nih.gov/2480412
https://pubmed.ncbi.nlm.nih.gov/2480412
Publikováno v:
Minerva medica. 80(3)
Tumor-associated trypsin inhibitor (TATI) is a 6 K dalton protease inhibitor, that was isolated from urine of a patient with ovarian cancer. In our experience, mean serum level of TATI in healthy subjects (n. 120), is 13 micrograms/l (range 5.1-42 mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::224f073c81a687a07902d762ef2e6d93
https://pubmed.ncbi.nlm.nih.gov/2717042
https://pubmed.ncbi.nlm.nih.gov/2717042